Evidence map›Paper›PMID 42846897›Full record

ReviewFundamental research2026

Recent advances in integrated biophysical and biochemical microfluidic methods for circulating tumor cells isolation and analysis.

Ruiju Shi, Yuyan Yue, Ziqi Liu, Hua Chai, Peng Miao

Abstract readReview
In one paragraph

Review in Fundamental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruiju ShiSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.
Yuyan YueShandong Laboratory of Advanced Biomaterials and Medical Devices in Weihai, Weihai 264200, China.
Ziqi LiuShandong Laboratory of Advanced Biomaterials and Medical Devices in Weihai, Weihai 264200, China.
Hua ChaiSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.
Peng MiaoSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a worldwide public health problem. Circulating tumor cells (CTCs) are one of the most significant tumor biomarkers, reflecting critical information of disease transcriptome, genome, and proteome. Various microfluidic methods have been proposed to separate, detect and analyze CTCs, involving multiple processes. In this work, we aim to give a comprehensive overview on recent advances in integrated biophysical and biochemical microfluidic methods for CTCs separation and detection. First, early label-free biophysical methods are introduced and discussed, including basic passive and active approaches as well as active-passive integrated assays. Next, we summarize labelled methods with different biochemical reactions based on their unique working principles, such as immune affinity-based methods and magnetic nanoparticle-assisted methods. Moreover, the most dominating approaches combining biochemical and biophysical methods are discussed. Their applicability and unique features are compared. Finally, we offer the perspectives on integrated microfluidic approaches for CTCs biosensing and cancer diagnostics.

Indexed as

AptamerCTCs biosensingCTCs isolationFluorescenceMagnetic nanoparticlesMicrofluidic chip

Identifiers

PMID42846897
PMCPMC13644408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.